The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
There are only 3 main things you need to know and remember about Andybe4.
1. He uses multiple profiles (at least 6). His main profile NDN71 was finally banned.
2. He has said in the past he is a female. He is now male and signs off under the name Drew.
3. He has posted stating he posts for fun, to troll others and to cause upset.
He is quite sinister and probably mentally deranged.
Axe
Are you drunk?
You are acting very weird.
You are the one who said you wanted to fist me. And you say I'm a Pervert. wtf.
Walk away from the keyboard. I'm going to do what I should have done ages ago and block you. But you are a good troll I will give you that. Total bizarre behaviour. Seek help.
Andybe4/Ndn
So based on your long post what are you doing here?
Are you some kind of Investment Vigilante. Like a superhero trying to save people from the riskiest type of share to invest in? Or are you just here to troll for your own amusement and fun.
There is still a need for a drug like ours.
Covid is here to stay for a long time. I am still very confident we will be on a trial by early 2023.
https://www.theguardian.com/world/2022/dec/20/china-rushes-to-boost-intensive-care-beds-doctors-and-stocks-of-medicine-as-covid-surges
Leyroygamble
Good post but frightening reading
The author of that post is no joe public. See below.
Eric Feigl-Ding
American scientist
OverviewNews
Eric Liang Feigl-Ding is an American public health scientist who is currently an epidemiologist and Chief of COVID Task Force at the New England Complex Systems Institute. He was formerly a faculty member and researcher at Harvard Medical School and Harvard T.H. Chan School of Public Health. Wikipedia
How those in power are not pushing for drugs like ours is shocking We need approved drugs on the shelf. Just one new high strain variant was to emerge this could cause mayhem.